Phase III trial data shows that a developmental drug, plinabulin, could help keep cancer patients on needed chemotherapy treatments.
Nerlynx (neratinib) demonstrates a 5.1% invasive disease-free survival benefit versus placebo in the phase III ExteNET trial evaluating Nerlynx in HER2-positive, hormone receptor-positive early stage breast cancer.
Hannah Hazard-Jenkins, associate chair of surgery for cancer services, was named the permanent director of the WVU Cancer Institute after having served in the position on an interim basis since January.
Edward S. Kim was named senior vice president and vice physician-in-chief at City of Hope, and physician-in-chief at City of Hope Orange County.
Julia H. Rowland, member of the National Coalition for Cancer Survivorship Board of Directors and former director of NCI's Office of Cancer Survivorship, and Thomas J. Smith, director of palliative medicine for Johns Hopkins Medicine, received the 2020 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care, presented by The National Coalition for Cancer Survivorship.
Jedd Wolchok received a $1 million grant over a three-year period from The William Randolph Hearst Foundation to establish a new immuno-oncology research fellowship at Memorial Sloan Kettering Cancer Center, and support postdoctoral students who are conducting exceptional research in the field of immune-oncology and immunotherapy.
The Cancer Prevention and Research Institute of Texas awarded nine new academic research grants totaling $26 million to recruit cancer researchers to Texas.
New policy adopted by physicians at the American Medical Association's Special Meeting of its House of Delegates recognizes racism as a public health threat and commits to actively work on dismantling racist policies and practices across all of health care.
Radiation oncologists across the country met virtually with members of Congress this week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based health care for people with cancer.
Karen E. Knudsen, MBA, PhD President, Association of American Cancer Institutes Enterprise director, Sidney Kimmel Cancer Center at Jefferson In a year of monumental health care and operational challenges for cancer centers, the Association of American Cancer Institutes marks with enthusiasm the electoral victory of a presidential candidate who has proven his unyielding commitment to defeating cancer.
